| Dr Alexander Vogel Uihlein, MD | |
|
900 S Eliseo Dr Ste 201, Greenbrae, CA 94904 | |
| (415) 461-1780 | |
| (415) 461-7378 |
| Full Name | Dr Alexander Vogel Uihlein |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 17 Years |
| Location | 900 S Eliseo Dr Ste 201, Greenbrae, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801043880 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.
WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies.
Three of the most common forms of anti-epileptic drugs in Denmark is associated with increase in patients' risk of suicide. However, the risk is low and should be seen in conjunction with the many beneficial effects of the medicines.
Biological siblings of people with gambling disorder also display markers of increased impulsivity and risk-taking, according to a new UBC psychology study. The findings, published today in Neuropsychopharmacology, suggest people with gambling disorder - a psychiatric term for serious gambling problems - may have pre-existing genetic vulnerabilities to the illness.
› Verified 3 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.
WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies.
Three of the most common forms of anti-epileptic drugs in Denmark is associated with increase in patients' risk of suicide. However, the risk is low and should be seen in conjunction with the many beneficial effects of the medicines.
Biological siblings of people with gambling disorder also display markers of increased impulsivity and risk-taking, according to a new UBC psychology study. The findings, published today in Neuropsychopharmacology, suggest people with gambling disorder - a psychiatric term for serious gambling problems - may have pre-existing genetic vulnerabilities to the illness.
› Verified 3 days ago
| Entity Name | Marin Healthcare District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659609964 PECOS PAC ID: 5698818011 Enrollment ID: O20100208000538 |
News Archive
The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.
WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies.
Three of the most common forms of anti-epileptic drugs in Denmark is associated with increase in patients' risk of suicide. However, the risk is low and should be seen in conjunction with the many beneficial effects of the medicines.
Biological siblings of people with gambling disorder also display markers of increased impulsivity and risk-taking, according to a new UBC psychology study. The findings, published today in Neuropsychopharmacology, suggest people with gambling disorder - a psychiatric term for serious gambling problems - may have pre-existing genetic vulnerabilities to the illness.
› Verified 3 days ago
| Entity Name | Regents Univ Of California Ucsf |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124439807 PECOS PAC ID: 6305160300 Enrollment ID: O20150122001375 |
News Archive
The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.
WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies.
Three of the most common forms of anti-epileptic drugs in Denmark is associated with increase in patients' risk of suicide. However, the risk is low and should be seen in conjunction with the many beneficial effects of the medicines.
Biological siblings of people with gambling disorder also display markers of increased impulsivity and risk-taking, according to a new UBC psychology study. The findings, published today in Neuropsychopharmacology, suggest people with gambling disorder - a psychiatric term for serious gambling problems - may have pre-existing genetic vulnerabilities to the illness.
› Verified 3 days ago
| Entity Name | Aristamd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235671660 PECOS PAC ID: 5092120816 Enrollment ID: O20210209000178 |
News Archive
The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.
WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies.
Three of the most common forms of anti-epileptic drugs in Denmark is associated with increase in patients' risk of suicide. However, the risk is low and should be seen in conjunction with the many beneficial effects of the medicines.
Biological siblings of people with gambling disorder also display markers of increased impulsivity and risk-taking, according to a new UBC psychology study. The findings, published today in Neuropsychopharmacology, suggest people with gambling disorder - a psychiatric term for serious gambling problems - may have pre-existing genetic vulnerabilities to the illness.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexander Vogel Uihlein, MD 900 S Eliseo Dr Ste 201, Greenbrae, CA 94904-2153 Ph: (415) 461-1780 | Dr Alexander Vogel Uihlein, MD 900 S Eliseo Dr Ste 201, Greenbrae, CA 94904 Ph: (415) 461-1780 |
News Archive
The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.
WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies.
Three of the most common forms of anti-epileptic drugs in Denmark is associated with increase in patients' risk of suicide. However, the risk is low and should be seen in conjunction with the many beneficial effects of the medicines.
Biological siblings of people with gambling disorder also display markers of increased impulsivity and risk-taking, according to a new UBC psychology study. The findings, published today in Neuropsychopharmacology, suggest people with gambling disorder - a psychiatric term for serious gambling problems - may have pre-existing genetic vulnerabilities to the illness.
› Verified 3 days ago
Dr. Albert A Varner, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1350 S Eliseo Dr, Ste 130, Greenbrae, CA 94904 Phone: 415-925-6900 Fax: 415-925-6919 | |
Dr. Kerry Lynn Davidson, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 250 Bon Air Rd, 3rd Floor, Greenbrae, CA 94904 Phone: 415-925-7545 Fax: 415-925-7008 | |
Timothy M Sowerby, MD Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 1350 S Eliseo Dr, Ste 130, Greenbrae, CA 94904 Phone: 415-925-6900 Fax: 415-925-6919 | |
Dr. Janeen Smith, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 250 Bon Air Rd, 3rd Floor, Greenbrae, CA 94904 Phone: 415-925-7545 Fax: 415-925-7008 | |
Dr. Maryam Ziaie Matin, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 501 Via Casitas, Greenbrae, CA 94904 Phone: 415-464-1771 Fax: 415-464-1158 | |
Dr. Suhaila Nawabi, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 250 Bon Air Rd, Greenbrae, CA 94904 Phone: 415-925-7000 | |
Mark Kubik, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 501 Via Casitas, Greenbrae, CA 94904 Phone: 415-464-1770 Fax: 415-464-1158 |